SANGAMO THERAPEUTICS, INC : Change in Directors or Principal Officers (form 8-K)

E COMMISSION
Washington, D.C. 20549
 
 FORM 8-K
 
 CURRENT REPORT
 Pursuant to Section 13 or 15(d)
 of the Securities Exchange Act of 1934
 Date of Report (Date of earliest event reported): February 11, 2020
 
SANGAMO THERAPEUTICS, INC.
(Exact name of registrant as specified in its charter)
 
Delawa

© Edgar Online, source Glimpses